Immunodiagnostics

 

Immunodiagnostic Services

Lab21 has comprehensive knowledge and experience in the development and commercialisation of immunodiagnostic assays, with especially detailed product and market knowledge in infectious disease.

Immunodiagnostic services available for clinical trials include the development and application of:
  • Gene synthesis, Protein Expression and Purification
  • Antibody production (Polyclonal and Monoclonal)
  • ELISA
  • Cell Agglutination (Haemaggluintation; Synthetic Particle-based Agglutination)
  • Immunoblot
  • FACS technologies
  • Point-of-care applications
  • Proprietary SelahDot™ technology for in vivo imaging, in vitro diagnostics, lateral flow devices, FRET
Lab21 can also offer Regulatory Approval and Commercialisation services for immunodiagnostics. We currently supply a wide variety of immunodiagnostic kits and reagents that are distributed into over 115 countries globally through our Diagnostic Products Division.